Cargando…
LncRNA-SLC6A9-5:2: a potent sensitizer in (131)I-resistant papillary thyroid carcinoma with PARP-1 induction
Recent studies have indicated that long non-coding RNAs play crucial roles in numerous cancers, including thyroid cancer, while their function in the mechanism of thyroid cancer (131)I resistance has not been elucidated to date. The present study identified a functional long non-coding RNA, SLC6A9-5...
Autores principales: | Xiang, Cheng, Zhang, Mao-lin, Zhao, Qun-zi, Xie, Qiu-ping, Yan, Hai-chao, Yu, Xing, Wang, Ping, Wang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410277/ https://www.ncbi.nlm.nih.gov/pubmed/28086241 http://dx.doi.org/10.18632/oncotarget.14578 |
Ejemplares similares
-
lncRNA CASC2 Enhances (131)I Sensitivity in Papillary Thyroid Cancer by Sponging miR-155
por: Tao, Ling, et al.
Publicado: (2020) -
LncRNA WT1-AS Downregulates Survivin by Upregulating miR-203 in Papillary Thyroid Carcinoma
por: Le, Fei, et al.
Publicado: (2020) -
BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer
por: Liao, Tian, et al.
Publicado: (2016) -
Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020) -
Diagnostic Value of Serum lncRNA HOTAIR Combined with Galectin-3 in Benign and Papillary Thyroid Carcinoma
por: Li, Li, et al.
Publicado: (2021)